Cargando…
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model
This study evaluated the clinical activity of RGN-259 (thymosin β4) in comparison with cyclosporine A (CsA), diquafosol (DQS), and lifitegrast (LFA) in a murine model of dry eye. The model was NOD.B10-H2(b) mice in a 30–40% humidified environment together with daily scopolamine hydrobromide injectio...
Autores principales: | Kim, Chae Eun, Kleinman, Hynda K., Sosne, Gabriel, Ousler, George W, Kim, Kyeongsoon, Kang, Sinwook, Yang, Jaewook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043477/ https://www.ncbi.nlm.nih.gov/pubmed/30002412 http://dx.doi.org/10.1038/s41598-018-28861-5 |
Ejemplares similares
-
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
por: Sosne, Gabriel, et al.
Publicado: (2022) -
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
por: Sosne, Gabriel, et al.
Publicado: (2015) -
Effects of silk fibroin in murine dry eye
por: Kim, Chae Eun, et al.
Publicado: (2017) -
Anti-inflammatory effects of glycine thymosin β4 eye drops in experimental dry eye
por: Jin, Rujun, et al.
Publicado: (2020) -
Corrigendum: Effects of silk fibroin in murine dry eye
por: Kim, Chae Eun, et al.
Publicado: (2017)